Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
Letters to the Editor

Mycobacterium avium subsp.paratuberculosis in Crohn’s Disease Is Serologically Positive

Saleh Naser, Ira Shafran
Saleh Naser
Department of Molecular Biology and Microbiology  and Center for Discovery of Drugs and Diagnostics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ira Shafran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/CDLI.6.2.282-282.1999
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Crohn’s disease, similar to Johne’s disease (aMycobacterium avium subsp.paratuberculosis-caused inflammatory bowel disease in ruminants and primates), is an inflammatory bowel disease with suspected mycobacterial etiology (1). The disease emerged perceptibly in Western Europe and North America in the late 1940s and early 1950s. The incidence then increased progressively on both continents to a level which in some areas, such as northeast Scotland (11.6/100,000 per year), now approaches that of an epidemic (4). Granulomas and lymph node alteration in Crohn’s disease patients resemble those of tuberculosis, leprosy, sarcoidosis, and bovine paratuberculosis (3). The latter has been suggested as a reservoir for epidemiologic transmission of the microorganism through contaminated dairy and meat products and possibly even in water (5).

In this study, we analyzed the humoral immune responses of Crohn’s disease patients compared with those of age-matched controls against two recombinant clones of M. avium subsp.paratuberculosis. The recombinant clones, designated p35 and p36 and expressing 35- and 36-kDa proteins, respectively, were identified from a previously constructed expression genomic library ofM. avium subsp. paratuberculosis that was screened by Western blotting against rabbit hyperimmune anti-M. avium subsp. paratuberculosis antibodies (2). A total of 110 human serum specimens, consisting of samples from 61 Crohn’s disease patients and 47 controls (35 volunteers with no history or symptoms of gastrointestinal tract disorder and 12 individuals diagnosed with ulcerative colitis) were analyzed by Western blotting (5). The participants who donated the sera used in this study were free of tuberculosis, leprosy, and/or had not received the Mycobacterium bovis BCG vaccine. As shown in Table 1, of the 61 Crohn’s disease-positive serum samples tested, 48 (79%) reacted with p35, 56 (92%) reacted with p36, 47 (77%) reacted with both antigens, and 57 (93%) reacted with either antigen. As expected, a small portion of Crohn’s disease-positive serum specimens, four (7%), did not react with either antigen. Of the 35 serum samples from healthy controls, 5 (14%) reacted with p35, 4 (11%) reacted with p36, none (0%) reacted with both antigens, and 9 (26%) reacted with either antigen. Of the 12 ulcerative colitis-positive serum specimens, only 1 (8%) reacted with p35 or p36, either individually or combined. The only ulcerative colitis patient who reacted positively with these antigens is under further evaluation for possibility of misdiagnosis. Crohn’s and ulcerative colitis diseases are inseparable at the early stage of infection. Many physicians refer to them as colitis diseases.

View this table:
  • View inline
  • View popup
Table 1.

Reactivities of serum samples from Crohn’s disease patients and controls with p35 and p36 recombinant antigens ofM. avium subsp. paratuberculosis

These data confirm that there is a statistically significant difference in reactivity between Crohn’s disease-positive serum samples and serum samples from controls (P < 0.001). This ultimately adds more evidence to strengthen the proposed association ofMycobacteria with Crohn’s disease. The data also suggest that there is great potential for using M. avium subsp.paratuberculosis recombinant antigens (p35 and p36) individually or combined in a serologic test for diagnosis and possibly in vaccine development.

ACKNOWLEDGMENTS

We would like to thank William Fenster for his work in carrying out the experiments and Anita Shafran for her role in blood specimen collection.

Our thanks are also due to the College of Health and Public Affairs at the University of Central Florida for financial support of this study.

  • Copyright © 1999 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Chiodini R. J.,
    2. Van Kruiningen H. J.,
    3. Thayer W. R.,
    4. Coutu J. A.
    Spheroplastic phase of mycobacteria isolated from patients with Crohn’s disease. J. Clin. Microbiol. 24 1986 357 363
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. El-Zaatari F. A. K.,
    2. Naser S. A.,
    3. Engstrand L.,
    4. et al.
    Identification and characterization of Mycobacterium paratuberculosis recombinant clones expressed in E. coli. Curr. Microbiol. 29 1994 177 184
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Graham D. Y.,
    2. Markesich D. G.,
    3. Kalter D. C.,
    4. et al.
    Mycobacterial aetiology of sarcoidosis. Lancet 340 1992 52 53
    OpenUrlPubMedWeb of Science
  4. 4.↵
    1. Kyle J.
    Crohn’s disease in the northeastern and northern Isles of Scotland: an epidemiological review. Gastroenterology 103 1992 392 399
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Millar D.,
    2. Ford J.,
    3. Sanderson J.,
    4. Withey S.,
    5. Tizard M.,
    6. Doran T.,
    7. Hermon-Taylor J.
    IS900 PCR to detect Mycobacterium paratuberculosis in retail supplies of whole pasteurized cows’ milk in England and Wales. Appl. Environ. Microbiol. 62 1996 3446 3452
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Mycobacterium avium subsp.paratuberculosis in Crohn’s Disease Is Serologically Positive
Saleh Naser, Ira Shafran
Clinical and Diagnostic Laboratory Immunology Mar 1999, 6 (2) 282; DOI: 10.1128/CDLI.6.2.282-282.1999

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Email

Thank you for sharing this Clinical and Vaccine Immunology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mycobacterium avium subsp.paratuberculosis in Crohn’s Disease Is Serologically Positive
(Your Name) has forwarded a page to you from Clinical and Vaccine Immunology
(Your Name) thought you would be interested in this article in Clinical and Vaccine Immunology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Mycobacterium avium subsp.paratuberculosis in Crohn’s Disease Is Serologically Positive
Saleh Naser, Ira Shafran
Clinical and Diagnostic Laboratory Immunology Mar 1999, 6 (2) 282; DOI: 10.1128/CDLI.6.2.282-282.1999
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X